Research and Markets: Updated Edition on Disease State Management Strategies II. Clinical Behavioral Health Guidelines 2009
* Reuters is not responsible for the content in this press release.
DUBLIN, Ireland--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/e88339/disease_state_mana) has announced the addition of the "Disease State Management Strategies II. Clinical Behavioral Health Guidelines, 2nd edition (update 2009)" report to their offering. Valuable clinical guidelines for the effective management of common, costly behavioral health disorders including Attention-deficit Hyperactivity Disorder (ADHD), Alzheimer's disease, Alcohol/substance abuse and dependency, Major depression, Bipolar, Obsessive-compulsive, and Anxiety/phobias/panic disorders including PTSD, Personality disorders, Impulse control, Conduct, Oppositional defiant disorders and Schizophrenia. Extensive references, resource materials, and related web sites follow each guideline. Useful tools for accreditation and quality improvement strategies. Updated as new information becomes available. Each guideline must be reviewed by the medical policy committee of the HMO or contracted/delegated medical group or other providers and modified and adapted as appropriate. It is strongly recommended that all applicable documents that will be used to manage medical care in the organization be sent to affected providers for review and comment prior to implementation. This will always promote an understanding of the guideline, avoid compliance issues, and frequently improve the document by the added input. This information is provided as a general reference and is not intended to address every aspect of a clinical situation that may exist now, or in the future. Physicians and health care professionals must exercise clinical discretion in interpreting and applying this information to individual patients. Any information in this manual is advisory and has been developed to assist healthcare professionals, together with patients, make decisions about the management of the patient's health. It is intended to support discussion and shared decision-making and is not a substitute for sound clinical judgement. Cost effective health care is quality driven (true quality, that is; not excessive care) and attention must always be focused on the issues that will result in optimal medical/surgical outcomes in the specific local medical environment. Guideline compliance remains a major issue. Neither CQI teams nor academic detailing have proven to be particularly effective. Key Topics Covered: * Introduction to this volume (Update 8-06) * Resource lists - Evidence-based Medicine in Behavioral Healthcare (Update 8-06) * Evidence-based Medicine web sites * Obstetrical guideline link - mental health (New 3-07) * 2007 JCAHO Behavioral Healthcare National Patient Safety Goals * JCAHO Tips for Avoiding Suicide * Alzheimer's disease ((updated 07-04, 1-05, 6-05, 11-05, 3-06, 2-07, 3-08, 12-08, 1-09) * Attention Deficit Hyperactivity Disorder (ADHD) (updated 10-04, 1-05, 2-06, 2-07, 11-07, 3-08, 10-08) * Alcohol/Substance Abuse and Dependency ((updated 12-04, 10-05, 9-06, 8-07, 10-07, 2-08. 11-08) * Anxiety, Phobias and Panic Disorder (updated 08-04, 10-05, 2-06, 2-07, 12-08) * Post-Traumatic Stress Disorder updated 08-04, 10-05, 2-06, 2-07, 12-08) * Bipolar Disorder(update 8-04, 12-04, 2-05, 6-05, 11-05, 1-07, 12-07, 12-08) * Personality Disorders (New 5-06) * Impulse Control Disorders (New 11-05, update 1-08) * Conduct Disorder (update 01-04, 8-06, 1-07, 1-08) * Oppositional Defiant Disorder (update 01-04, 12-08) * Child and Adolescent Behavioral Health Issues (New 6-07, update 12-08) * Cognitive Mental Disorders in children or adolescents - due to a general medical condition (1999, update 1-08) * Schizophrenia - guideline, resources (update 8-05, 12-05, 4-06, 9-06, 1-07, 3-07, 11-07, 2-08, 2-09) For more information visit http://www.researchandmarkets.com/research/e88339/disease_state_mana Laura Wood Senior Manager press@researchandmarkets.com Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters